Back
Outlook Therapeutics Vs. Predictive Oncology Industry Stock Comparison
Sell
25
OTLK
Outlook Therapeutics
Last Price:
5.76
Seasonality Move:
-12.63%
Sell
29
POAI
Predictive Oncology
Last Price:
0.71
Seasonality Move:
-8.32%
Sell
25
Outlook Therapeutics (OTLK)
is a Sell
Is Outlook Therapeutics a Buy, Sell or Hold?
- The current Outlook Therapeutics [OTLK] share price is $5.75. The Score for OTLK is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- OTLK is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
29
Predictive Oncology (POAI)
is a Sell
Is Predictive Oncology a Buy, Sell or Hold?
- The current Predictive Oncology [POAI] share price is $0.71. The Score for POAI is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- POAI is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
OTLK Stock Price Chart
What is Outlook Therapeutics's stock price today?
-
The Outlook Therapeutics share price today is $5.75
The current trend is relatively stagnant and OTLK is experiencing slight selling pressure.
POAI Stock Price Chart
What is Predictive Oncology's stock price today?
-
The Predictive Oncology share price today is $0.71
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and POAI is experiencing selling pressure, which indicates risk of future bearish movement.
OTLK Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.07 | Sell |
| Relative Strength Index (14 RSI): | 53.97 | Buy |
| Chaikin Money Flow: | -24041 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.11 - 5.61) | Buy |
| Bollinger Bands (100): | (5.79 - 8.01) | Sell |
POAI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 47.9 | Sell |
| Chaikin Money Flow: | -61368 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.63 - 0.77) | Buy |
| Bollinger Bands (100): | (0.75 - 1.15) | Sell |
OTLK Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.58 | Buy |
| 20-day SMA: | 5.34 | Buy |
| 50-day SMA: | 6.11 | Sell |
| 200-day SMA: | 7.54 | Sell |
| 8-day EMA: | 5.61 | Buy |
| 20-day EMA: | 5.55 | Buy |
| 50-day EMA: | 6 | Sell |
| 200-day EMA: | 8.18 | Sell |
POAI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.74 | Sell |
| 20-day SMA: | 0.68 | Buy |
| 50-day SMA: | 0.8 | Sell |
| 200-day SMA: | 1.63 | Sell |
| 8-day EMA: | 0.74 | Sell |
| 20-day EMA: | 0.72 | Sell |
| 50-day EMA: | 0.81 | Sell |
| 200-day EMA: | 1.65 | Sell |
Outlook Therapeutics Earnings Growth & OTLK Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.39 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.74 per share, and an increase next year of $1.39 per share.
Predictive Oncology Earnings Growth & POAI Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Outlook Therapeutics Technical Analysis
| Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Predictive Oncology Technical Analysis
| Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||